NCT05605587 |
|
Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial
|
View
|
NCT03846219 |
|
MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis EMPhASIS
|
View
|
NCT05007236 |
|
Study to Evaluate the Efficacy and Safety of Oral RP7214 a DHODH Inhibitor in Patients With Symptomatic Mild COVID-19 Infection
|
View
|
NCT05166876 |
|
Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19
|
View
|
NCT05246384 |
|
Study to Evaluate the Safety Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
|
View
|
NCT03451084 |
|
A Dose Optimisation Study of ASLAN003 in Acute Myeloid Leukemia
|
View
|
NCT03709446 |
|
Leflunomide in Previously Treated Metastatic Triple Negative Cancers
|
View
|
NCT03760666 |
|
A Study of Brequinar in Subjects With RelapsedRefractory Acute Myeloid Leukemia
|
View
|
NCT03761069 |
|
Study of PTC299 Emvododstat in RelapsedRefractory Acute Leukemias
|
View
|
NCT04680429 |
|
A Single and Multiple Ascending and Food Effect Study of RP7214 a DHODH Inhibitor in Healthy Adult Subjects
|
View
|
NCT03834584 |
|
A Study of AG-636 in the Treatment of Subjects With Advanced Lymphoma
|
View
|
NCT05007678 |
|
Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease
|
View
|
NCT04425252 |
|
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
|
View
|
NCT04609826 |
|
A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia AML or Myelodysplastic Syndrome MDS
|
View
|
NCT05865041 |
|
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
|
View
|
NCT03404726 |
|
A Study to Investigate BAY2402234 a Dihydroorotate Dehydrogenase DHODH Inhibitor in Myeloid Malignancies
|
View
|